Patents by Inventor Kevin Grove

Kevin Grove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123655
    Abstract: A rodstock barrel drive having a first and second roller gears, each having a toothed section and a gripping surface section, such that the teeth of the roller gears intermesh, causing rotation of one of roller gear to rotate the other roller gear in the opposite direction, so as to draw a rodstock through a space between the gripping surfaces of the pair of roller gears, a ring gear which engages with one of the pair of roller gears, a drive gear which engages with the ring gear, and one or more idler gears which engage with the ring gear, all within a housing, the drive gear being connected to, and rotated by, a motor, which causes the rodstock to be drawn through the roller gears, wherein all the gears are all positioned within, and oriented parallel to, a common plane.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 18, 2024
    Applicant: Rolls-Royce plc
    Inventors: Kevin M. WORLD, Simon Groves, Wojciech Wasinski
  • Publication number: 20240123692
    Abstract: A needle apparatus for making a pinning hole in a composite material, the apparatus having a needle with a longitudinal axis, a collar fixed about the needle, a motor having an axis of rotation, and being fixed to the needle such that the needle can be rotated by the motor, the motor and the collar being situated within a motor housing, the motor housing having a first bush, and a second bush, wherein the collar is positioned between the first bush and second bush so as to prevent the needle from moving away from or towards the motor, but allow the needle to rotate freely around its longitudinal axis, wherein each needle apparatus further comprises a linear actuator connected to the motor such that the motor can be moved along the axis of rotation of the motor by the linear actuator.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 18, 2024
    Applicant: ROLLS-ROYCE plc
    Inventors: Kevin M. WORLD, Simon GROVES, Wojciech WASINSKI, Neal WRIGHT
  • Publication number: 20230159762
    Abstract: This disclosure provides a family of compounds that absorb and fluoresce in the short wave infrared region (SWIR, optionally 1000 nm to 1300 nm), including hydrophilic compounds that exhibit absorption and emission spectral profiles in aqueous solutions substantially similar to those observed in organic solvents such as methanol or DMSO. The compounds can be chemically linked to biomolecules including proteins, nucleic acids, and therapeutic small molecules. The compounds are useful for imaging in a variety of medical, biological and diagnostic applications, including SWIR in vivo imaging of regions of interest within a mammal.
    Type: Application
    Filed: December 7, 2022
    Publication date: May 25, 2023
    Inventors: Nara Narayanan, Kevin Groves, Guojie Ho
  • Patent number: 11549017
    Abstract: This disclosure provides a family of compounds that absorb and fluoresce in the short wave infrared region (SWIR, optionally 1000 nm to 1300 nm), including hydrophilic compounds that exhibit absorption and emission spectral profiles in aqueous solutions substantially similar to those observed in organic solvents such as methanol or DMSO. The compounds can be chemically linked to biomolecules including proteins, nucleic acids, and therapeutic small molecules. The compounds are useful for imaging in a variety of medical, biological and diagnostic applications, including SWIR in vivo imaging of regions of interest within a mammal.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: January 10, 2023
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Nara Narayanan, Kevin Groves, Guojie Ho
  • Publication number: 20220023277
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 27, 2022
    Inventors: Kevin Groves, Bagna Bao
  • Patent number: 11059802
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: July 13, 2021
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Bagna Bao
  • Publication number: 20210172942
    Abstract: Presented herein are methods, systems, and apparatus for single analyte detection or multiplexed analyte detection based on amplified luminescent proximity homogeneous assay (“alpha”) technology, but using hollow polymer fiber optics doped with ‘acceptor bead’ dye (e.g., thioxene, anthracene, rubrene, and/or lanthanide chelates) or ‘donor bead’ dye (e.g., phthalocyanine) that carry a signal generated by the dopant via singlet oxygen channeling.
    Type: Application
    Filed: February 2, 2021
    Publication date: June 10, 2021
    Inventors: Roger Bossé, Wael I. Yared, Peter A. Harvey, Kevin Groves, Ilias Faqir, Michael Meltzer
  • Patent number: 10942177
    Abstract: Presented herein are methods, systems, and apparatus for single analyte detection or multiplexed analyte detection based on amplified luminescent proximity homogeneous assay (“alpha”) technology, but using hollow polymer fiber optics doped with ‘acceptor bead’ dye (e.g., thioxene, anthracene, rubrene, and/or lanthanide chelates) or ‘donor bead’ dye (e.g., phthalocyanine) that carry a signal generated by the dopant via singlet oxygen channeling.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: March 9, 2021
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Roger Bossé, Wael I. Yared, Peter A. Harvey, Kevin Groves, Ilias Faqir, Michael Meltzer
  • Publication number: 20200232926
    Abstract: Presented herein are methods, systems, and apparatus for single analyte detection or multiplexed analyte detection based on amplified luminescent proximity homogeneous assay (“alpha”) technology, but using hollow polymer fiber optics doped with ‘acceptor bead’ dye (e.g., thioxene, anthracene, rubrene, and/or lanthanide chelates) or ‘donor bead’ dye (e.g., phthalocyanine) that carry a signal generated by the dopant via singlet oxygen channeling.
    Type: Application
    Filed: February 25, 2020
    Publication date: July 23, 2020
    Inventors: Roger Bossé, Wael I. Yared, Peter A. Harvey, Kevin Groves, Ilias Faqir, Michael Meltzer
  • Patent number: 10677735
    Abstract: Presented herein are methods, systems, and apparatus for single analyte detection or multiplexed analyte detection based on amplified luminescent proximity homogeneous assay (“alpha”) technology, but using hollow polymer fiber optics doped with ‘acceptor bead’ dye (e.g., thioxene, anthracene, rubrene, and/or lanthanide chelates) or ‘donor bead’ dye (e.g., phthalocyanine) that carry a signal generated by the dopant via singlet oxygen channeling.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: June 9, 2020
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Roger Bossé, Wael I. Yared, Peter A. Harvey, Kevin Groves, Ilias Faqir, Michael Meltzer
  • Patent number: 10442930
    Abstract: This invention relates to new fluorescent chemical entities, especially fluorescent molecules that comprise biocompatible N, N-disubstituted sulfonamide fluorochromes. This invention also relates to the corresponding reactive versions of such molecules. This invention also relates to the corresponding conjugates with moieties such as peptides, proteins, various biomolecules, carbocyclic and heterocyclic compounds, sugars, and their uses thereof.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: October 15, 2019
    Assignee: VisEn Medical, Inc.
    Inventors: Narasimhachari Narayanan, Kevin Groves, Jeffrey D. Peterson, Milind Rajopadhye
  • Publication number: 20190300501
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Application
    Filed: February 27, 2019
    Publication date: October 3, 2019
    Inventors: Kevin Groves, Bagna Bao
  • Publication number: 20190100654
    Abstract: This disclosure provides a family of compounds that absorb and fluoresce in the short wave infrared region (SWIR, optionally 1000 nm to 1300 nm), including hydrophilic compounds that exhibit absorption and emission spectral profiles in aqueous solutions substantially similar to those observed in organic solvents such as methanol or DMSO. The compounds can be chemically linked to biomolecules including proteins, nucleic acids, and therapeutic small molecules. The compounds are useful for imaging in a variety of medical, biological and diagnostic applications, including SWIR in vivo imaging of regions of interest within a mammal.
    Type: Application
    Filed: September 7, 2018
    Publication date: April 4, 2019
    Inventors: Nara Narayanan, Kevin Groves, Guojie Ho
  • Patent number: 10221159
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: March 5, 2019
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Bagna Bao
  • Patent number: 9999687
    Abstract: Provided is a family of intramolecularly quenched imaging agents for use in both in vivo and in vitro imaging that contain at least one enzymatically cleavable oligopeptide and two fluorophores or a fluorophore and a quencher. When subjected to proteolytic cleavage, at least one fluorophore is unquenched and becomes capable of producing a fluorescent signal upon excitation with light of an appropriate wavelength. Also provided are in vivo and in vitro imaging methods using such imaging agents.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: June 19, 2018
    Assignee: VisEn Medical, Inc.
    Inventors: Milind Rajopadhye, Kevin Groves, Dorin V. Preda
  • Patent number: 9913917
    Abstract: The invention relates to highly fluorescent metal oxide nanoparticles to which biomolecules and other compounds can be chemically linked to form biocompatible, stable optical imaging agents for in vitro and in vivo applications. The fluorescent metal oxide nanoparticles may also be used for magnetic resonance imaging (MRI), thus providing a multi modality imaging agent.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: March 13, 2018
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Milind Rajopadhye
  • Publication number: 20170283617
    Abstract: This invention relates to new fluorescent chemical entities, especially fluorescent molecules that comprise biocompatible N, N-disubstituted sulfonamide fluorochromes. This invention also relates to the corresponding reactive versions of such molecules. This invention also relates to the corresponding conjugates with moieties such as peptides, proteins, various biomolecules, carbocyclic and heterocyclic compounds, sugars, and their uses thereof.
    Type: Application
    Filed: February 15, 2017
    Publication date: October 5, 2017
    Inventors: Narasimhachari Narayanan, Kevin Groves, Jeffrey D. Peterson, Milind Rajopadhye
  • Publication number: 20170167984
    Abstract: Presented herein are methods, systems, and apparatus for single analyte detection or multiplexed analyte detection based on amplified luminescent proximity homogeneous assay (“alpha”) technology, but using hollow polymer fiber optics doped with ‘acceptor bead’ dye (e.g., thioxene, anthracene, rubrene, and/or lanthanide chelates) or ‘donor bead’ dye (e.g., phthalocyanine) that carry a signal generated by the dopant via singlet oxygen channeling.
    Type: Application
    Filed: November 22, 2016
    Publication date: June 15, 2017
    Inventors: Roger Bossé, Wael I. Yared, Peter A. Harvey, Kevin Groves, Ilias Faqir, Michael Meltzer
  • Patent number: 9649389
    Abstract: The invention provides a family of fluorescent compounds. The compounds are substituted silaxanthenium compounds that can be chemically linked to one or more biomolecules, such as a protein, nucleic acid, and therapeutic small molecule. The compounds can be used for imaging in a variety of medical, biological and diagnostic applications. The dyes are particularly useful for in vitro, in vivo and ex vivo imaging applications.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: May 16, 2017
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Ryan Buff
  • Publication number: 20170119908
    Abstract: Provided is a family of intramolecularly quenched imaging agents for use in both in vivo and in vitro imaging that contain at least one enzymatically cleavable oligopeptide and two fluorophores or a fluorophore and a quencher. When subjected to proteolytic cleavage, at least one fluorophore is unquenched and becomes capable of producing a fluorescent signal upon excitation with light of an appropriate wavelength. Also provided are in vivo and in vitro imaging methods using such imaging agents.
    Type: Application
    Filed: August 29, 2016
    Publication date: May 4, 2017
    Inventors: Milind Rajopadhye, Kevin Groves, Dorin V. Preda